Patents by Inventor Hong Xue

Hong Xue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11952593
    Abstract: The present disclosure provides in vitro methods for predicting a compound's ability to inhibit multinucleate cell production resulting from post-mitotic cell fusion during a process of Daughter Number Variation (DNV) in mitosis. Compounds identified by this method can be used in cancer treatment, either alone or in combination with other known cancer drugs. The present invention also provides methods of personalized cancer treatment for a patient having a malignant tumor.
    Type: Grant
    Filed: October 6, 2021
    Date of Patent: April 9, 2024
    Inventor: Hong Xue
  • Patent number: 11634774
    Abstract: A method for identifying one or more genomic variations in human genomic DNA, comprising employment of Alu, MIR and SVA sequence-based PCR primers and performing an inter-transposable-element (ITE) polymerase chain reaction on the assay mixture to produce an array of amplicons comprising the ITE genomic segments. Also provided the use of the method for identifying one or more genomic variants associated with a trait or a disease.
    Type: Grant
    Filed: May 18, 2018
    Date of Patent: April 25, 2023
    Assignee: PharmacoGenetics Limited
    Inventor: Hong Xue
  • Publication number: 20220105071
    Abstract: The present disclosure provides in vitro methods for predicting a compound's ability to inhibit multinucleate cell production resulting from post-mitotic cell fusion during a process of Daughter Number Variation (DNV) in mitosis. Compounds identified by this method can be used in cancer treatment, either alone or in combination with other known cancer drugs. The present invention also provides methods of personalized cancer treatment for a patient having a malignant tumor.
    Type: Application
    Filed: October 6, 2021
    Publication date: April 7, 2022
    Inventor: Hong Xue
  • Patent number: 11067831
    Abstract: Methods are disclosed for manufacturing a coated contact lens that comprises a polymeric lens body comprising an acid group, a first coating polymer comprising a first amine group ionically bound to the acid group, and a second coating bound to the first coating polymer through covalent linkage between a nitrogen atom of a second amine group on the first coating polymer and an amine-reactive group of the second coating polymer. In some examples the lenses exhibit improved surface properties compared to uncoated lenses, such as reduced adhesion, increased wettability, increased lubricity, and/or increased lipid resistance.
    Type: Grant
    Filed: September 20, 2018
    Date of Patent: July 20, 2021
    Assignee: COOPERVISION INTERNATIONAL LIMITED
    Inventors: Hong Xue, Yuwen Liu
  • Publication number: 20210209313
    Abstract: The present disclosure embodiment may disclose translation methods and systems. The translation method may include: obtaining a content to be translated in a first language; translating the content to be translated in the first language into a pre-translated content including a second language; correcting the pre-translated content including the second language; and determining a final translated content based on a correction result. The present disclosure may improve the accuracy of machine translation and the efficiency of manual revision by translating part of the content to be translated in advance and correcting and identifying part of the pre-translated content including the second language.
    Type: Application
    Filed: November 18, 2019
    Publication date: July 8, 2021
    Applicant: METIS IP (SUZHOU) LLC
    Inventors: Yan LI, Hong QIAN, Hong XUE
  • Publication number: 20210164049
    Abstract: A method for identifying one or more genomic variations in human genomic DNA, comprising employment of Alu, MIR and SVA sequence-based PCR primers and performing an inter-transposable-element (ITE) polymerase chain reaction on the assay mixture to produce an array of amplicons comprising the ITE genomic segments. Also provided the use of the method for identifying one or more genomic variants associated with a trait or a disease.
    Type: Application
    Filed: May 18, 2018
    Publication date: June 3, 2021
    Inventor: Hong Xue
  • Patent number: 10873323
    Abstract: A low-power transmitter for transmitting digital signals from an integrated chip is described herein. The transmitter includes a voltage-mode transmitter driver comprised of a plurality of driver slices, which includes an up-cell having a first resistor and a first transistor, and a down-cell having a second resistor, a second transistor, and a third transistor. A calibration circuit drives a replica circuit to a desired impedance by adjusting a first gate voltage applied to the first transistor of the replica of the up-cell and adjusting a second gate voltage applied to the third transistor of the replica of the down-cell. The calibrated first gate voltage is applied to the first transistor and to the second transistor of each of the plurality of driver slices and the calibrated second gate voltage is applied to the third transistor of each of the plurality of driver slices.
    Type: Grant
    Filed: January 31, 2020
    Date of Patent: December 22, 2020
    Assignee: Marvell Asia Pte, Ltd.
    Inventors: Fei Guo, Yihui Li, Hong Xue, Xin Ma, Hui Wang
  • Patent number: 10855254
    Abstract: Systems for calibrating impedances caused by a first component and a second component of a voltage-mode transmitter driver are described herein. The first component includes a first transistor and a first resistor connected to the first transistor, wherein the first component is connected to a voltage source and an output end of the voltage-mode transmitter driver, respectively. The second component includes a second transistor and a second resistor connected to the second transistor, wherein the second component is connected to the output end of the voltage-mode transmitter driver, and a third transistor, respectively. A first gate of the third transistor is applied with a first tunable gate voltage, and the first tunable gate voltage is configured to be tuned to calibrate a first impedance between the output end and a ground to match with a second impedance between the voltage source and the output end.
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: December 1, 2020
    Assignee: Marvell Asia Pte, Ltd.
    Inventors: Fei Guo, Yihui Li, Hong Xue, Xin Ma, Hui Wang
  • Patent number: 10842788
    Abstract: The compound levorotatory-tetrahydropalmatine and pharmaceutical compositions thereof are provided for the treatment of ‘depressant disorders’, ‘bipolar and related disorders’, ‘manic episodes’ and ‘anxiety disorders’ as these disorders are defined in Diagnostic and Statistical Manual of Mental Disorders 5th Edition (DSM-5).
    Type: Grant
    Filed: July 19, 2019
    Date of Patent: November 24, 2020
    Assignee: PharmacoGenetics Limited
    Inventor: Hong Xue
  • Publication number: 20200252055
    Abstract: Systems for calibrating impedances caused by a first component and a second component of a voltage-mode transmitter driver are described herein. The first component includes a first transistor and a first resistor connected to the first transistor, wherein the first component is connected to a voltage source and an output end of the voltage-mode transmitter driver, respectively. The second component includes a second transistor and a second resistor connected to the second transistor, wherein the second component is connected to the output end of the voltage-mode transmitter driver, and a third transistor, respectively. A first gate of the third transistor is applied with a first tunable gate voltage, and the first tunable gate voltage is configured to be tuned to calibrate a first impedance between the output end and a ground to match with a second impedance between the voltage source and the output end.
    Type: Application
    Filed: January 31, 2019
    Publication date: August 6, 2020
    Inventors: Fei Guo, Yihui Li, Hong Xue, Xin Ma, Hui Wang
  • Publication number: 20200252057
    Abstract: A low-power transmitter for transmitting digital signals from an integrated chip is described herein. The transmitter includes a voltage-mode transmitter driver comprised of a plurality of driver slices, which includes an up-cell having a first resistor and a first transistor, and a down-cell having a second resistor, a second transistor, and a third transistor. A calibration circuit drives a replica circuit to a desired impedance by adjusting a first gate voltage applied to the first transistor of the replica of the up-cell and adjusting a second gate voltage applied to the third transistor of the replica of the down-cell. The calibrated first gate voltage is applied to the first transistor and to the second transistor of each of the plurality of driver slices and the calibrated second gate voltage is applied to the third transistor of each of the plurality of driver slices.
    Type: Application
    Filed: January 31, 2020
    Publication date: August 6, 2020
    Inventors: Fei Guo, Yihui Li, Hong Xue, Xin Ma, Hui Wang
  • Patent number: 10722547
    Abstract: Compositions comprising extracts prepared from mixtures of the herbal plants Radix Bupleurum chinense DC (“B”), Rhizoma Corydalis yanhusuo WT Wang (“Y”), Caulis Polygonum multiflorum Thunb (“P”) and Flos Albizia julibrissin Durazz (“A”) are provided. The BYP, BYA, BPA, BY, BP, YP and BYPA extracts significantly decreased one or more of the effects of accelerated aging in mice exposed to D-galactose, including spatial memory deficit, and elevated oxidative stress marker malondialdehyde and pro-inflammatory cytokines TNF-alpha and IL-6 in the brain, indicating efficacy in reducing the damage of aging, and preventing and treating Alzheimer's disease and/or Parkinson's disease. Anxiolysis by the BYA, BPA, YPA, BA and PA extracts indicates efficacy for treating anxiety disorders, and the sedative effect of the BYA, YPA and PA extracts indicates efficacy for treating sleep disorders.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: July 28, 2020
    Assignee: PharmacoGenetics Limited
    Inventor: Hong Xue
  • Patent number: 10675558
    Abstract: A dispersed mobile-phase countercurrent chromatography system is described in which solutes are carried by a stream of dispersed mobile phase solvent through a column, or array of serially-connected columns, of stationary phase solvent with which the mobile phase solvent is immiscible. Solutes carried along by the stream of dispersed mobile-phase solvent will be equilibrated between the mobile-phase solvent and the stationary-phase solvent. Because the mobile-phase is dispersed into mini-droplets much smaller in diameter than the column of stationary phase, the enhanced surface/volume ratio of the droplets expedites countercurrent equilibration of different solutes between the mobile-phase solvent and the stationary-phase solvent in accordance with the distribution-coefficients of the solutes between the two solvents.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: June 9, 2020
    Assignee: The Hong Kong University of Science and Technology
    Inventors: Yiu Cheong Ho, Jeffrey Tze Fei Wong, Hong Xue
  • Patent number: 10544312
    Abstract: Marine coatings including cationic polymers hydrolyzable to nonfouling zwitterionic polymers, coated marine surfaces, and methods for making and using the marine coatings.
    Type: Grant
    Filed: December 29, 2016
    Date of Patent: January 28, 2020
    Assignee: University of Washington
    Inventors: Shaoyi Jiang, Yuting Li, Hong Xue, Shengfu Chen
  • Publication number: 20200022970
    Abstract: The compound levorotatory-tetrahydropalmatine and pharmaceutical compositions thereof are provided for the treatment of ‘depressant disorders’, ‘bipolar and related disorders’, ‘manic episodes’ and ‘anxiety disorders’ as these disorders are defined in Diagnostic and Statistical Manual of Mental Disorders 5th Edition (DSM-5).
    Type: Application
    Filed: July 19, 2019
    Publication date: January 23, 2020
    Inventor: Hong Xue
  • Patent number: 10433066
    Abstract: A micro speaker includes a planar diaphragm, spacers respectively disposed at one side surface of the planar diaphragm, an upper plate and a lower plate, one or more magnets and a circuit board. The planar diaphragm includes a vibrating diaphragm and a coil conductor. The coil conductor is stretched and bonded onto the vibrating diaphragm via an adhesive layer on the upper side surface of the planar diaphragm; the coil conductor is electrically connected to the circuit board. The speaker in this present invention can get a diameter of 15 mm or less, and a height is 5 mm or less.
    Type: Grant
    Filed: October 11, 2018
    Date of Patent: October 1, 2019
    Inventor: Hong Xue
  • Publication number: 20190297426
    Abstract: A micro speaker includes a planar diaphragm, spacers respectively disposed at one side surface of the planar diaphragm, an upper plate and a lower plate, one or more magnets and a circuit board. The planar diaphragm includes a vibrating diaphragm and a coil conductor. The coil conductor is stretched and bonded onto the vibrating diaphragm via an adhesive layer on the upper side surface of the planar diaphragm; the coil conductor is electrically connected to the circuit board. The speaker in this present invention can get a diameter of 15 mm or less, and a height is 5 mm or less.
    Type: Application
    Filed: October 11, 2018
    Publication date: September 26, 2019
    Inventor: HONG XUE
  • Publication number: 20190129202
    Abstract: Methods are disclosed for manufacturing a coated contact lens that comprises a polymeric lens body comprising an acid group, a first coating polymer comprising a first amine group ionically bound to the acid group, and a second coating bound to the first coating polymer through covalent linkage between a nitrogen atom of a second amine group on the first coating polymer and an amine-reactive group of the second coating polymer. In some examples the lenses exhibit improved surface properties compared to uncoated lenses, such as reduced adhesion, increased wettability, increased lubricity, and/or increased lipid resistance.
    Type: Application
    Filed: September 20, 2018
    Publication date: May 2, 2019
    Applicant: CooperVision International Holding Company, LP
    Inventors: Hong Xue, Yuwen Liu
  • Publication number: 20190070300
    Abstract: Zwitterionic polymer and mixed charge copolymer bioconjugates, methods for making and using the bioconjugates.
    Type: Application
    Filed: November 15, 2018
    Publication date: March 7, 2019
    Applicant: University of Washington through its Center for Commercialization
    Inventors: Shaoyi Jiang, Andrew Keefe, Hong Xue
  • Patent number: 10130716
    Abstract: Zwitterionic polymer and mixed charge copolymer bioconjugates, methods for making and using the bioconjugates.
    Type: Grant
    Filed: October 29, 2014
    Date of Patent: November 20, 2018
    Assignee: University of Washington through its Center for Commercialization
    Inventors: Shaoyi Jiang, Andrew Keefe, Hong Xue